Transplacental transfer of acrylamide and glycidamide are comparable to that of antipyrine in perfused human placenta.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
AbstractMost drugs can penetrate the placenta but there are only a few studies on placental transfer of environmental toxic compounds. In this study, we used dual recirculating human placental perfusion to determine the transfer rate through the placenta of a neurotoxic and carcinogenic compound found in food, acrylamide and its genotoxic metabolite glycidamide. Putative acrylamide metabolism into glycidamide during the 4-h perfusions and acrylamide-derived DNA adducts in placental DNA after perfusions were also analyzed. Placentas were collected immediately after delivery and kept physiologically functional as confirmed by antipyrine kinetics, glucose consumption and leak from fetal to maternal circulation. Acrylamide (5 or 10 microg/ml) or glycidamide (5 microg/ml), both with antipyrine (100 microg/ml), was added to maternal circulation. Acrylamide and glycidamide were analyzed in the perfusion medium by liquid chromatography/mass spectrometry. Acrylamide and glycidamide crossed the placenta from maternal to fetal circulation with similar kinetics to antipyrine, suggesting fetal exposure if the mother is exposed. The concentrations in maternal and fetal circulations equilibrated within 2h for both studied compounds and with both concentrations. Acrylamide metabolism into glycidamide was not detected during the 4-h perfusions. Moreover, DNA adducts were undetectable in the placentas after perfusions. However, fetuses may be exposed to glycidamide after maternal metabolism. Although not found in placental tissue after 4h of perfusion, it is possible that glycidamide adducts are formed in fetal DNA.
CitationToxicol. Lett. 2008, 182 (1-3):50-56
SponsorsFinally, we appreciate the collaboration with all members in Dan Segerbäck’s group, partner of the Network of Excellence ECNIS. This project was financially supported by EU networks NewGeneris (FOOD-CT-2005 016320) and ReProTect (LSHB-CT-2004-503257).
- Simultaneous determination of acrylamide, its metabolite glycidamide and antipyrine in human placental perfusion fluid and placental tissue by liquid chromatography-electrospray tandem mass spectrometry.
- Authors: Annola K, Keski-Rahkonen P, Vähäkangas K, Lehtonen M
- Issue date: 2008 Dec 15
- Transplacental transfer of nitrosodimethylamine in perfused human placenta.
- Authors: Annola K, Heikkinen AT, Partanen H, Woodhouse H, Segerbäck D, Vähäkangas K
- Issue date: 2009 Mar
- Criteria and challenges of the human placental perfusion – Data from a large series of perfusions.
- Authors: Karttunen V, Sahlman H, Repo JK, Woo CS, Myöhänen K, Myllynen P, Vähäkangas KH
- Issue date: 2015 Oct
- An examination of whether human placental perfusion allows accurate prediction of placental drug transport: studies with diazepam.
- Authors: Myllynen P, Vähäkangas K
- Issue date: 2002 Nov-Dec
- Transplacental passage of vancomycin in the ex vivo human perfusion model.
- Authors: Hnat MD, Gainer J, Bawdon RE, Wendel GD Jr
- Issue date: 2004 Jun